Related Experiment Video

Updated: May 2, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

2.0K

A review of drug therapy for neonatal hypertension

Michele J Beaulieu, Christina Carsello

    Neonatal Network : NN
    |March 5, 2014
    PubMed

    Insights

    Neonatal hypertension is increasingly diagnosed due to improved premature infant survival and invasive monitoring. Defining normal blood pressure (BP) and effective treatments remains challenging, with limited data on neonatal hypertension outcomes.

    Area of Science:

    • Neonatal medicine
    • Pediatric cardiology
    • Clinical pharmacology

    Background:

    • Neonatal hypertension is a growing concern, linked to increased survival of premature infants.
    • Higher rates of intravascular access and invasive blood pressure monitoring contribute to diagnosis.
    • Establishing normal blood pressure ranges and diagnostic criteria in neonates is complex and evolving.

    Purpose of the Study:

    • To review the current understanding and challenges in diagnosing neonatal hypertension.
    • To outline existing antihypertensive medication classes for neonates.
    • To highlight the limitations in research regarding neonatal hypertension treatment and outcomes.

    Main Methods:

    • Literature review of studies on neonatal hypertension.
    • Analysis of diagnostic challenges and evolving normal blood pressure parameters.
    • Overview of available antihypertensive drug classes and their application in neonates.

    Main Results:

    • Neonatal hypertension diagnosis is complicated by evolving definitions and normal BP ranges.
    • Five classes of antihypertensives are available for neonatal use.
    • There is a significant lack of clinical studies guiding treatment and limited data on long-term outcomes.

    Conclusions:

    • Further research is critically needed to establish clear diagnostic guidelines for neonatal hypertension.
    • Evidence-based treatment protocols for neonatal hypertension are lacking.
    • Understanding the outcomes of neonatal hypertension is essential for improving infant care.

    Keywords:
    angiotensin-converting enzyme inhibitors (ACEI)antihypertensiveshypertension

    More Related Videos

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

    Published on: August 25, 2014

    90.5K
    Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

    Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

    Published on: March 28, 2025

    717

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    408
    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
    1.0K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    554
    Hypertension V: Nursing Management01:23

    Hypertension V: Nursing Management

    The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
    687
    Drug Therapy01:28

    Drug Therapy

    The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
    Antianxiety Medications
    449
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    1.0K